FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376865497> ?p ?o ?g. }

• W4376865497 endingPage "101857" @default.
• W4376865497 startingPage "101857" @default.
• W4376865497 abstract "Belatacept may provide benefit in delayed graft function, but its association with infectious complications is understudied. We aim to assess the incidence of CMV and BK viremia in patients treated with sirolimus or belatacept as part of a three-drug immunosuppression regimen after kidney transplantation. Kidney transplant recipients from 01/01/2015 to 10/01/2021 were retrospectively reviewed. Maintenance immunosuppression was either tacrolimus, mycophenolate and sirolimus (B0) or tacrolimus, mycophenolate, and belatacept (5.0 mg/kg monthly) (B1). Primary outcomes of interest were BK and CMV viremia which were followed until the end of the study period. Secondary outcomes included graft function (serum creatinine, eGFR) and acute rejection through 12 months. Belatacept was initiated in patients with a higher mean kidney donor profile index (B0:0.36 vs. B1:0.44, p = .02) with more delayed graft function (B0:6.1% vs. B1:26.1%, p < .001). Belatacept therapy was associated with more “severe” CMV viremia >25,000 copies/mL (B0:1.2% vs. B1:5.9%, p = .016) and CMV disease (B0:0.41% vs. B1:4.2%, p = .015). However, there was no difference in the overall incidence of CMV viremia >200 IU/mL (B0:9.4% vs. B1:13.5%, p = .28). There was no difference in the incidence of BK viremia >200 IU/mL (B0:29.7% vs. B1:31.1%, p = .78) or BK-associated nephropathy (B0:2.4% vs. B1:1.7%, p = .58), but belatacept was associated with “severe” BK viremia, defined as >10,000 IU/mL (B0:13.0% vs. B1:21.8%, p = .03). The mean serum Cr was significantly higher with belatacept therapy at 1-year follow up (B0:1.24 mg/dL vs. B1:1.43 mg/dL, p = .003). Biopsy-proven acute rejection (B0:1.2% vs. B1:2.6%, p = .35) and graft loss (B0:1.2% vs. B1:0.84%, p = .81) were comparable at 12 months. Belatacept therapy was associated with an increased risk of CMV disease and “severe” CMV and BK viremia. However, this regimen did not increase the overall incidence of infection and facilitated comparable acute rejection and graft loss at 12-month follow up." @default.
• W4376865497 created "2023-05-18" @default.
• W4376865497 creator A5007515278 @default.
• W4376865497 creator A5007793369 @default.
• W4376865497 creator A5012279286 @default.
• W4376865497 creator A5016270207 @default.
• W4376865497 creator A5031853535 @default.
• W4376865497 creator A5038081603 @default.
• W4376865497 creator A5046693774 @default.
• W4376865497 creator A5074744295 @default.
• W4376865497 creator A5077574370 @default.
• W4376865497 date "2023-08-01" @default.
• W4376865497 modified "2023-09-26" @default.
• W4376865497 title "Increased CMV disease and “severe” BK viremia with belatacept vs. sirolimus three-drug maintenance immunosuppression" @default.
• W4376865497 cites W1889499446 @default.
• W4376865497 cites W1971278669 @default.
• W4376865497 cites W2011384694 @default.
• W4376865497 cites W2077684987 @default.
• W4376865497 cites W2080372833 @default.
• W4376865497 cites W2091236576 @default.
• W4376865497 cites W2098856442 @default.
• W4376865497 cites W2102048011 @default.
• W4376865497 cites W2127894722 @default.
• W4376865497 cites W2142161841 @default.
• W4376865497 cites W2154181237 @default.
• W4376865497 cites W2167694671 @default.
• W4376865497 cites W2170264508 @default.
• W4376865497 cites W2171522478 @default.
• W4376865497 cites W2302846155 @default.
• W4376865497 cites W2792992809 @default.
• W4376865497 cites W2913029142 @default.
• W4376865497 cites W2922316313 @default.
• W4376865497 cites W2924992665 @default.
• W4376865497 cites W2942868034 @default.
• W4376865497 cites W2966739547 @default.
• W4376865497 cites W2977763430 @default.
• W4376865497 cites W2982984149 @default.
• W4376865497 cites W2989011832 @default.
• W4376865497 cites W2991178342 @default.
• W4376865497 cites W3005349797 @default.
• W4376865497 cites W3009348385 @default.
• W4376865497 cites W3033820682 @default.
• W4376865497 cites W3188846643 @default.
• W4376865497 doi "https://doi.org/10.1016/j.trim.2023.101857" @default.
• W4376865497 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37201797" @default.
• W4376865497 hasPublicationYear "2023" @default.
• W4376865497 type Work @default.
• W4376865497 citedByCount "1" @default.
• W4376865497 countsByYear W43768654972023 @default.
• W4376865497 crossrefType "journal-article" @default.
• W4376865497 hasAuthorship W4376865497A5007515278 @default.
• W4376865497 hasAuthorship W4376865497A5007793369 @default.
• W4376865497 hasAuthorship W4376865497A5012279286 @default.
• W4376865497 hasAuthorship W4376865497A5016270207 @default.
• W4376865497 hasAuthorship W4376865497A5031853535 @default.
• W4376865497 hasAuthorship W4376865497A5038081603 @default.
• W4376865497 hasAuthorship W4376865497A5046693774 @default.
• W4376865497 hasAuthorship W4376865497A5074744295 @default.
• W4376865497 hasAuthorship W4376865497A5077574370 @default.
• W4376865497 hasConcept C126322002 @default.
• W4376865497 hasConcept C126894567 @default.
• W4376865497 hasConcept C203014093 @default.
• W4376865497 hasConcept C2522874641 @default.
• W4376865497 hasConcept C2776185481 @default.
• W4376865497 hasConcept C2777921159 @default.
• W4376865497 hasConcept C2780252810 @default.
• W4376865497 hasConcept C2780303639 @default.
• W4376865497 hasConcept C2780743877 @default.
• W4376865497 hasConcept C2909675724 @default.
• W4376865497 hasConcept C2911091166 @default.
• W4376865497 hasConcept C2994498544 @default.
• W4376865497 hasConcept C71924100 @default.
• W4376865497 hasConcept C90924648 @default.
• W4376865497 hasConceptScore W4376865497C126322002 @default.
• W4376865497 hasConceptScore W4376865497C126894567 @default.
• W4376865497 hasConceptScore W4376865497C203014093 @default.
• W4376865497 hasConceptScore W4376865497C2522874641 @default.
• W4376865497 hasConceptScore W4376865497C2776185481 @default.
• W4376865497 hasConceptScore W4376865497C2777921159 @default.
• W4376865497 hasConceptScore W4376865497C2780252810 @default.
• W4376865497 hasConceptScore W4376865497C2780303639 @default.
• W4376865497 hasConceptScore W4376865497C2780743877 @default.
• W4376865497 hasConceptScore W4376865497C2909675724 @default.
• W4376865497 hasConceptScore W4376865497C2911091166 @default.
• W4376865497 hasConceptScore W4376865497C2994498544 @default.
• W4376865497 hasConceptScore W4376865497C71924100 @default.
• W4376865497 hasConceptScore W4376865497C90924648 @default.
• W4376865497 hasLocation W43768654971 @default.
• W4376865497 hasLocation W43768654972 @default.
• W4376865497 hasOpenAccess W4376865497 @default.
• W4376865497 hasPrimaryLocation W43768654971 @default.
• W4376865497 hasRelatedWork W1938774068 @default.
• W4376865497 hasRelatedWork W2078851746 @default.
• W4376865497 hasRelatedWork W2154163950 @default.
• W4376865497 hasRelatedWork W2738297065 @default.
• W4376865497 hasRelatedWork W2883381352 @default.
• W4376865497 hasRelatedWork W3010430700 @default.
• W4376865497 hasRelatedWork W3083464738 @default.

• next